ERBB2 and neoplasm: Because the sample sizes for the Triple Negative (only 4) and HER2-enriched (only 2) are too small, and more than 1/3 of samples’ subtypes are not available, the methylation analysis based on the tumor subtypes of our data will not represent the population patterns.